PODD Insulet Corp.
$150.03
Insulet Corp. (PODD) is expected to report earnings on February 3, 2027, before the market open. The consensus earnings estimate is $1.74 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.0% since its last earnings release on November 4, 2026.
Insulet Beat Expectations, Narrows Guidance
Wednesday, November 4, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 7:00 AM ET
Earnings Whisper
-
vs $1.74
Rev est $899.69M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$154.41
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Insulet Corp.
Insulet Corp is a medical device company that develops, manufactures and markets OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
Sector
Healthcare
Industry
Medical Appliances/Equipment
Charts powered in part by Lightweight Charts™ by TradingView.